Eaton Corporation plc vs 10X Genomics Inc — how do they compare? Eaton Corporation plc trades at $395.5 (market cap $160.31B), while 10X Genomics Inc trades at $42.6 (market cap $5.81B). The key difference: Eaton Corporation plc is far larger — about 27.6× 10X Genomics Inc's market cap, and Eaton Corporation plc pays a 1.07% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| ETN | TXG | |
|---|---|---|
Market Cap | $160.31B | $5.81B |
Sector | Technology | Health |
52-Week High | $435.78 | $45.80 |
52-Week Low | $315.82 | $11.34 |
Enterprise Value | $181.40B | $5.35B |
Dividend Yield | 1.07% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
10x Genomics (TXG) trades at $42.56, down 7.07% today, with mixed technical signals showing bullish moving averages but overbought RSI levels. The company demonstrates strong revenue stability around $640M annually and improving profitability trends, with net losses narrowing significantly from -$255M in 2023 to -$44M in 2025. Recent strategic moves include the Proteintech Genomics acquisition and Cleveland Clinic collaboration to expand multiomics capabilities.
While the company shows promising margin improvement and strategic growth initiatives, investors face valuation concerns with elevated P/S and EV/EBITDA ratios. The mixed analyst sentiment (45% buy, 50% hold) and consensus price target below current levels suggest cautious optimism. Key risks include ongoing profitability challenges and competitive pressures in the life sciences tools market.
Trailing returns across standard periods
Latest headlines on both assets
Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →